glp 1 egfr cut off GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity 2. Integration of SGLT2i in
Description
It was an active player, releasing chemical messengersincretinsthat acted like advanced scouts, warning the pancreas: Foods on the way, get the insulin ready. By the mid-70s, researchers had narrowed the suspects down to two main hormones: GIP (glucose-dependent insulinotropic polypeptide) GLP-1 (glucagon-like peptide-1), destined to become the star Fast forward to the 1980s
Diabetes Obes Metab 22(4):492500
Psychiatry 28 , 19021918 (2023)
they seek insights that help them make better decisions
